Debut Biotechnology
launched plant-cell biotechnology creating fragrance ingredients without cultivation (2026 PR Newswire launch) and partnered with Oterra to scale a biotech alternative to Red 40 for food and beverage — the reference plant-cell platform whose rare-molecule fermentation route is extensible to capsaicinoids.
- Country
- United States
Plant-cell biotechnology; cultivation-free rare-molecule fermentation; founded 2019
us
Coverage
| EU | IN | US | |
|---|---|---|---|
| specialty-fine-chem | ✓ | ✓ | ✓ |
Regulatorsfdaefsa
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Biosynthetic capsaicin | specialty-fine-chem | Medium | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.